Cell counting is a process used in determining the cell count in individuals. This process is useful in identifying the presence of infectious diseases. The prevalence of cancers, AIDS, and other chronic disorders has made cell counting instruments, such as flow cytometers, imperative hospitals and clinics for the disease diagnosis and treatment.
The process plays a valuable role in determining the viability of cells in 3D cell culture. 3D cell culture is fundamental in researching viral vaccines and it bolsters the development of stem cells to be used for transplantation purposes. The different types of cell counting instruments used in clinical diagnosis include spectrophotometers, flow cytometers, automated cell counters, and hemocytometers.
Automated Instruments to Provide Novel Insights
The automated cell counters segment is expected to register a healthy CAGR over the forecast period (from 2018 to 2025) due to short test times and low error rates. The increasing use of immunotherapy drugs for cancer treatment is expected to drive the demand for this segment. The Vi-CELL XR automated cell analyzer by Beckman Coulter has the ability to accurately count the number of dendritic cells required for immunotherapy drugs.
The spectrophotometers segment captured a large market share in 2016 on account of the introduction of magnified data visualization analysis software in these devices. Advances in spectroscopy methods have provided biologists with additional tools to analyze bacteria strains and observe their growth stages. For instance, the spectrophotometers by Mettler-Toledo International, Inc., provide spectra and color analyses of large samples simultaneously.
Market Overview
According to a report by Grand View Research, Inc., the global cell counting market is projected to reach USD 1.7 billion by 2025, expanding at 6.9% CAGR from 2018 to 2025. Rising prevalence of chronic diseases, such as AIDS and cancer, along with the developments in stem cell research is expected to spur the market growth.
Use of data visualization analysis software and demand for biopharmaceuticals are anticipated to bolster market expansion. Government initiatives encouraging research of cell therapeutics will also have positive impact on the market development. Key companies in this market include Becton, Dickinson (BD) and Company; Thermo Fisher Scientific, Inc.; Merck KGaA; and Agilent Technologies.
In-Depth Research Report On Cell Counting Market:
https://www.grandviewresearch.com/industry-analysis/cell-counting-market
No comments:
Post a Comment